Literature DB >> 2062801

Degradation of insulin by trypsin and alpha-chymotrypsin.

R J Schilling1, A K Mitra.   

Abstract

The rate and extent of insulin degradation by trypsin and alpha-chymotrypsin were examined in vitro, and the initial sites of cleavage by alpha-chymotrypsin were identified. The apparent Km for both enzymes was approximately the same but the apparent Vmax for alpha-chymotrypsin was 8.6 times greater. At a molar ratio of 172:1 (insulin:enzyme), chymotrypsin caused near-total loss of insulin within 40 min, while very little insulin was degraded by trypsin. Chymotrypsin appeared to cleave initially at the carboxyl side of the B26-Tyr and A19-Tyr residues, and additional cleavage at the B16-Tyr, B25-Phe, and A14-Tyr residue sites also occurred rapidly. Only two to three other susceptible bonds, which are not exposed at the surface of the insulin molecule, remained intact after the quenching of initial cleavage. Four of the amino acids involved in initial cleavage are essential for receptor binding ability, making it difficult to modify insulin chemically to achieve greater stability without losing activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062801     DOI: 10.1023/a:1015893832222

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Studies on the enzymatic breakdown of proteins. I. Action of chymotrypsin on insulin.

Authors:  A GINSBURG; H K SCHACHMAN
Journal:  J Biol Chem       Date:  1960-01       Impact factor: 5.157

2.  Effect of trypsin inhibitor on passage of insulin across the intestinal barrier.

Authors:  M LASKOWSKI; H A HAESSLER; R P MIECH; R J PEANASKY; M LASKOWSKI
Journal:  Science       Date:  1958-05-09       Impact factor: 47.728

3.  Further observations on the action of chymotrypsin on insulin.

Authors:  D M P PHILLIPS
Journal:  Biochem J       Date:  1951-09       Impact factor: 3.857

4.  Absorption of insulin from the human small intestine.

Authors:  C W Crane; G R Luntz
Journal:  Diabetes       Date:  1968-10       Impact factor: 9.461

5.  Effect of new chymotrypsin inhibitor (FK-448) on intestinal absorption of insulin.

Authors:  M Shinomiya; K Shirai; Y Saito; S Yoshida; N Matsuoka
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

6.  Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.

Authors:  M Kobayashi; M Haneda; H Maegawa; N Watanabe; Y Takada; Y Shigeta; K Inouye
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

7.  The absorption of insulin from various regions of the rat intestine.

Authors:  M Kidron; H Bar-On; E M Berry; E Ziv
Journal:  Life Sci       Date:  1982-12-20       Impact factor: 5.037

8.  Preparation and characterization of desoctapeptide-insulin.

Authors:  W W Bromer; R E Chance
Journal:  Biochim Biophys Acta       Date:  1967-02-21

9.  Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.

Authors:  M Kobayashi; S Ohgaku; M Iwasaki; H Maegawa; Y Shigeta; K Inouye
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

10.  A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.

Authors:  F B Stentz; R K Wright; A E Kitabchi
Journal:  Diabetes       Date:  1982-12       Impact factor: 9.461

View more
  22 in total

1.  Sensitive electrospray mass spectrometry analysis of one-bead-one-compound peptide libraries labeled by quaternary ammonium salts.

Authors:  Remigiusz Bąchor; Marzena Cydzik; Magdalena Rudowska; Alicja Kluczyk; Piotr Stefanowicz; Zbigniew Szewczuk
Journal:  Mol Divers       Date:  2012-06-28       Impact factor: 2.943

2.  Chemical and alpha-chymotrypsin-mediated proteolytic degradation of insulin in bile salt-unsaturated fatty acid mixed micellar systems.

Authors:  Y Li; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

3.  Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).

Authors:  J P Bai; M J Hsu; W T Shier
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

4.  Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

Authors:  F Y Liu; D O Kildsig; A K Mitra
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

5.  Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.

Authors:  Z Shao; Y Li; T Chermak; A K Mitra
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

6.  Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution.

Authors:  H Asada; T Douen; Y Mizokoshi; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  Pharmacodynamics of insulin following intravenous and enteral administrations of porcine-zinc insulin to rats.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, alpha-chymotryptic degradation, and enteral absorption of insulin hexamers.

Authors:  Z Shao; Y Li; R Krishnamoorthy; T Chermak; A K Mitra
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

9.  Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Improving the stability of insulin in solutions containing intestinal proteases in vitro.

Authors:  Liefeng Zhang; Hui Jiang; Wenjie Zhu; Lin Wu; Lingling Song; Qiuyan Wu; Yong Ren
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.